Price $4.02 |
Market Cap
681.3M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
4.36
|
P/S
14.68
|
Dividend %
-
|
|
P/CF
4.5
|
P/FCF
-
|
Op. Cash Flow
-48.9K
|
FCF
-0.3
|
|
Op. Margin
-127.00%
|
Net Margin
-124.00%
|
ROE
-37.50%
|
ROI
-47.40%
|
|
ROA
-21.60%
|
EPS Growth
13.70%
|
Current Ratio
2.2
|
Debt/Equity
1.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| AcelRx Pharmaceuticals Inc (ACRX) | $0.49 | - | - | 67.1M | Strong Buy |
| Acura Pharmaceuticals, Inc. (ACUR) | $0.48 | - | - | 32.8M | Strong Buy |
| Agenus Inc (AGEN) | $2.68 | - | - | 865.5M | Strong Buy |
| Akumin Inc (AKU) | $1.51 | - | - | 184.9M | Strong Buy |
| AngioDynamics, Inc. (ANGO) | $22.12 | - | - | 1.09B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
